New Jersey Assembly Bill A2015

New Jersey 2026-2027 Regular Session

• Introduced: 1/13/26
• Refer: 1/13/26

Caption

Requires manufacturer of recalled medical devices to provide replacement device or pay for replacement device under certain circumstances.

Impact

The enactment of A2015 will significantly affect state consumer protection laws by strengthening regulations surrounding medical device recalls. Manufacturers will be obligated to take immediate steps to mitigate risks posed by faulty devices, thus promoting higher safety standards within the medical device market. In situations of non-compliance, the act identifies violations as unlawful practices under New Jersey’s Consumer Fraud Act, potentially leading to significant penalties for manufacturers, including fines and additional damages for consumers.

Summary

Assembly Bill A2015 requires manufacturers of recalled medical devices to provide a replacement device at no cost to consumers or pay for a replacement from another manufacturer if a compliant replacement is not available. This initiative aims to enhance consumer safety and responsibility within the medical device industry, ensuring that manufacturers are held accountable for their products when they pose health risks to users. The bill empowers consumers by mandating immediate action from manufacturers once a recall is issued, ideally within a 30-day timeframe from notice.

Contention

Debate surrounding A2015 may revolve around the implications of imposing strict requirements on manufacturers. Proponents argue that such measures are crucial for protecting consumers, especially in an industry where device failures can lead to severe health consequences. However, some stakeholders might express concerns regarding the feasibility and financial impact on manufacturers, particularly smaller firms who may struggle with compliance costs associated with swiftly providing replacements or compensating for devices. Additionally, discussions may focus on the balance between ensuring consumer safety and avoiding excessive regulatory burdens on businesses.